Complement deficiency promotes cutaneous wound healing in mice

Journal of Immunology

Volumn 194, Issue 3, 2015, Pages 1285-1291

  Rafail, Stavros ^a   Kourtzelis, Ioannis ^a,b   Foukas, Periklis G ^c   Markiewski, Maciej M ^a   DeAngelis, Robert A ^a   Guariento, Mara ^a   Ricklin, Daniel ^a   Grice, Elizabeth A ^d   Lambris, John D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR 2; UNCLASSIFIED DRUG; COMPLEMENT; COMPLEMENT RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT DEFICIENCY; COMPLEMENT INHIBITION; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOLOGY; HUMAN; INFLAMMATORY INFILTRATE; MALE; MAST CELL; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN INJURY; WOUND HEALING; ANIMAL; BIOLOGICAL MODEL; DEFICIENCY; DISEASE MODEL; GENETICS; IMMUNOLOGY; INFLAMMATION; INJURIES; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SKIN;

ANIMALS; COMPLEMENT C3; COMPLEMENT C5A; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, COMPLEMENT; SKIN; WOUND HEALING;

EID: 84921490493     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402354     Document Type: Article

References (46)

1. Martin, P. 1997. Wound healing - aiming for perfect skin regeneration. Science 276: 75-81.
2. Singer, A. J., and R. A. Clark. 1999. Cutaneous wound healing. N. Engl. J. Med. 341: 738-746.
3. Wilgus, T. A. 2008. Immune cells in the healing skin wound: influential players at each stage of repair. Pharmacol. Res. 58: 112-116.
4. Bickers, D. R., H. W. Lim, D. Margolis, M. A. Weinstock, C. Goodman, E. Faulkner, C. Gould, E. Gemmen, and T. Dall, American Academy of Dermatology Association, Society for Investigative Dermatology. 2006. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J. Am. Acad. Dermatol. 55: 490-500.
5. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
6. Huber-Lang, M., J. V. Sarma, F. S. Zetoune, D. Rittirsch, T. A. Neff, S. R. McGuire, J. D. Lambris, R. L. Warner, M. A. Flierl, L. M. Hoesel, et al. 2006. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12: 682-687.
7. Pasch, M. C., N. H. Van Den Bosch, M. R. Daha, J. D. Bos, and S. S. Asghar. 2000. Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines. J. Invest. Dermatol. 114: 78-82.
8. Sinno, H., and S. Prakash. 2013. Complements and the wound healing cascade: an updated review. Plast. Surg. Int. 2013: 146764.
9. Bossi, F., C. Tripodo, L. Rizzi, R. Bulla, C. Agostinis, C. Guarnotta, C. Munaut, G. Baldassarre, G. Papa, S. Zorzet, et al. 2014. C1q as a unique player in angiogenesis with therapeutic implication in wound healing. Proc. Natl. Acad. Sci. USA 111: 4209-4214.
10. Sinno, H., M. Malholtra, J. Lutfy, B. Jardin, S. Winocour, F. Brimo, L. Beckman, K. Watters, A. Philip, B. Williams, and S. Prakash. 2013. Topical application of complement C3 in collagen formulation increases early wound healing. J. Dermatolog. Treat. 24: 141-147.
11. Sinno, H., M. Malhotra, J. Lutfy, B. Jardin, S. Winocour, F. Brimo, L. Beckman, K. Watters, A. Philip, B. Williams, and S. Prakash. 2012. Accelerated wound healing with topical application of complement C5. Plast. Reconstr. Surg. 130: 523-529.
12. Cazander, G., G. N. Jukema, and P. H. Nibbering. 2012. Complement activation and inhibition in wound healing. Clin. Dev. Immunol. 2012: 534291.
13. Wahl, S. M., W. P. Arend, and R. Ross. 1974. The effect of complement depletion on wound healing. Am. J. Pathol. 75: 73-89.
14. Jalili, A., N. Shirvaikar, L. Marquez-Curtis, Y. Qiu, C. Korol, H. Lee, A. R. Turner, M. Z. Ratajczak, and A. Janowska-Wieczorek. 2010. Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells. Exp. Hematol. 38: 321-332.
15. Tsonis, P. A., J. D. Lambris, and K. Del Rio-Tsonis. 2006. To regeneration⋯ with complement. Adv. Exp. Med. Biol. 586: 63-70.
16. Cole, D. S., T. R. Hughes, P. Gasque, and B. P. Morgan. 2006. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis. Mol. Immunol. 43: 1953-1964.
17. Alexander, J. J., A. J. Anderson, S. R. Barnum, B. Stevens, and A. J. Tenner. 2008. The complement cascade: Yin-Yang in neuroinflammation - neuroprotection and -degeneration. J. Neurochem. 107: 1169-1187.
18. Carmona-Fontaine, C., E. Theveneau, A. Tzekou, M. Tada, M. Woods, K. M. Page, M. Parsons, J. D. Lambris, and R. Mayor. 2011. Complement fragment C3a controls mutual cell attraction during collective cell migration. Dev. Cell 21: 1026-1037.
19. Sundberg, J. P., L. B. Nanney, P. Fleckman, and L. E. King. 2012. Skin and adnexa. In Comparative Anatomy and Histology. P. M. Treuting, and S. M. Dintzis, eds. Academic Press, San Diego, CA, p. 433-455.
20. Basta, M., and C. H. Hammer. 1991. A rapid FPLC method for purification of the third component of human and guinea pig complement. J. Immunol. Methods 142: 39-44.
21. Langer, H. F., K.-J. Chung, V. V. Orlova, E. Y. Choi, S. Kaul, M. J. Kruhlak, M. Alatsatianos, R. A. DeAngelis, P. A. Roche, P. Magotti, et al. 2010. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 116: 4395-4403.
22. Gullstrand, B., U. Mårtensson, G. Sturfelt, A. A. Bengtsson, and L. Truedsson. 2009. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin. Exp. Immunol. 156: 303-311.
23. Ward, P. A. 2010. Role of C5 activation products in sepsis. Scientific World Journal 10: 2395-2402.
24. Teh, B. K., J. G. Yeo, L. M. Chern, and J. Lu. 2011. C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Mol. Immunol. 48: 1128-1138.
25. Fang, C., X. Zhang, T. Miwa, and W. C. Song. 2009. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 114: 1005-1015.
26. Jameson, J., K. Ugarte, N. Chen, P. Yachi, E. Fuchs, R. Boismenu, and W. L. Havran. 2002. A role for skin gammadelta T cells in wound repair. Science 296: 747-749.
27. Mills, R. E., K. R. Taylor, K. Podshivalova, D. B. McKay, and J. M. Jameson. 2008. Defects in skin gamma delta T cell function contribute to delayed wound repair in rapamycin-treated mice. J. Immunol. 181: 3974-3983.
28. Brubaker, A. L., D. F. Schneider, and E. J. Kovacs. 2011. Neutrophils and natural killer T cells as negative regulators of wound healing. Expert Rev. Dermatol. 6: 5-8.
29. Cass, D. L., K. M. Bullard, K. G. Sylvester, E. Y. Yang, M. T. Longaker, and N. S. Adzick. 1997. Wound size and gestational age modulate scar formation in fetal wound repair. J. Pediatr. Surg. 32: 411-415.
30. Dovi, J. V., L.-K. He, and L. A. DiPietro. 2003. Accelerated wound closure in neutrophil-depleted mice. J. Leukoc. Biol. 73: 448-455.
31. Martin, P., D. D'Souza, J. Martin, R. Grose, L. Cooper, R. Maki, and S. R. McKercher. 2003. Wound healing in the PU.1 null mouse - tissue repair is not dependent on inflammatory cells. Curr. Biol. 13: 1122-1128.
32. Goren, I., E. Müller, D. Schiefelbein, U. Christen, J. Pfeilschifter, H. Mühl, and S. Frank. 2007. Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J. Invest. Dermatol. 127: 2259-2267.
33. Goren, I., H. Kämpfer, M. Podda, J. Pfeilschifter, and S. Frank. 2003. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes 52: 2821-2832.
34. Chehoud, C., S. Rafail, A. S. Tyldsley, J. T. Seykora, J. D. Lambris, and E. A. Grice. 2013. Complement modulates the cutaneous microbiome and inflammatory milieu. Proc. Natl. Acad. Sci. USA 110: 15061-15066.
35. Crivellato, E., B. Nico, and D. Ribatti. 2008. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett. 269: 1-6.
36. Jung, M., M. S. Lord, B. Cheng, J. G. Lyons, H. Alkhouri, J. M. Hughes, S. J. McCarthy, R. V. Iozzo, and J. M. Whitelock. 2013. Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing. J. Biol. Chem. 288: 3289-3304.
37. Fukuoka, Y., H.-Z. Xia, L. B. Sanchez-Muñoz, A. L. Dellinger, L. Escribano, and L. B. Schwartz. 2008. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5. J. Immunol. 180: 6307-6316.
38. Ali, H. 2010. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Immunol. Lett. 128: 36-45.
39. Kashem, S. W., H. Subramanian, S. J. Collington, P. Magotti, J. D. Lambris, and H. Ali. 2011. G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2. Eur. J. Pharmacol. 668: 299-304.
40. Kambas, K., A. Chrysanthopoulou, I. Kourtzelis, M. Skordala, I. Mitroulis, S. Rafail, S. Vradelis, I. Sigalas, Y.-Q. Wu, M. Speletas, et al. 2011. Endothelin-1 signaling promotes fibrosis in vitro in a bronchopulmonary dysplasia model by activating the extrinsic coagulation cascade. J. Immunol. 186: 6568-6575.
41. Ritis, K., M. Doumas, D. Mastellos, A. Micheli, S. Giaglis, P. Magotti, S. Rafail, G. Kartalis, P. Sideras, and J. D. Lambris. 2006. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J. Immunol. 177: 4794-4802.
42. Binnie, C. G., and S. T. Lord. 1993. The fibrinogen sequences that interact with thrombin. Blood 81: 3186-3192.
43. Blombäck, B., B. Hessel, D. Hogg, and L. Therkildsen. 1978. A two-step fibrinogen - fibrin transition in blood coagulation. Nature 275: 501-505.
44. Wong, V. W., M. Sorkin, J. P. Glotzbach, M. T. Longaker, and G. C. Gurtner. 2011. Surgical approaches to create murine models of human wound healing. J. Biomed. Biotechnol. 2011: 969618.
45. Qu, H., D. Ricklin, and J. D. Lambris. 2009. Recent developments in low molecular weight complement inhibitors. Mol. Immunol. 47: 185-195.
46. Ricklin, D., and J. D. Lambris. 2007. Complement-targeted therapeutics. Nat. Biotechnol. 25: 1265-1275.